These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8788444)

  • 1. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-801 blocks the expression but not the development of tolerance to morphine in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):289-96. PubMed ID: 8788443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
    Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
    Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
    Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
    Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
    J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
    Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal.
    Maldonado C; Cauli O; Rodríguez-Arias M; Aguilar MA; Miñarro J
    Behav Brain Res; 2003 Sep; 144(1-2):25-35. PubMed ID: 12946592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
    Kawasaki Y; Jin C; Suemaru K; Kawasaki H; Shibata K; Choshi T; Hibino S; Gomita Y; Araki H
    Br J Pharmacol; 2005 Jul; 145(6):751-7. PubMed ID: 15880144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
    Shoemaker WJ; Kosten TA; Muly SM
    Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of MK-801 in morphine-dependent and non-dependent mice.
    Belozertseva I; Zvartau E; Bespalov A
    Life Sci; 1996; 58(4):PL55-61. PubMed ID: 8538362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactive effects of MK-801 and morphine on EEG, EEG power spectra and behavior in rats: II. Morphine dependence.
    Haberny KA; Young GA
    Eur J Pharmacol; 1994 Aug; 261(1-2):11-6. PubMed ID: 8001632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
    Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
    Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of sacral spinal cord neurons to the autonomic and somatic consequences of withdrawal from morphine in the rat.
    Rohde DS; McKay WR; Abbadie C; Basbaum AI
    Brain Res; 1997 Jan; 745(1-2):83-95. PubMed ID: 9037396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
    Buccafusco JJ; Terry AV; Shuster L
    Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
    Kotlińska J
    Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
    Zhu H; Barr GA
    Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids.
    Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T
    Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
    Christensen D; Guilbaud G; Kayser V
    Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
    Yeh GC; Tao PL; Chen JY; Lai MC; Gao FS; Hu CL
    Eur J Pharmacol; 2002 Oct; 453(2-3):197-202. PubMed ID: 12398904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.